Cell Therapeutics, Inc. (NASDAQ:CTIC)

Headlines for Cell Therapeutics, Inc.

CTIC: Wins Federal Court Appeal to Pursue $22.8 Million Claim vs The Lash Group
Trading Markets - 19 hours ago
Cell Therapeutics, Inc. (CTIC) announced that the Ninth Circuit Court of Appeals reversed a US District Court order and ruled that CTIC should be allowed to pursue all of its claims against The ...
RidgewaterEquity.com Free Fundamental Sector & Market Research on NITE, TIBX, CTIC, KLAC, BMRN and E
PR-USA.net - Nov 19, 2009
RidgewaterEquity.com inspires to bring the best from the internet under one roof, providing you with a one click option to view what the market, researchers and financial pundits worldwide have to ...
Cell Therapeutics (CTIC), (THRX), (DARA), (GILD), (TRBN), (OXGN):FDA & Clinical Trial Dates
Live-PR.com - Nov 19, 2009
THRX: awaits decision from the FDA for its new drug application for telavancin a novel, bactericidal, oncedaily injectable inestigational antibiotic, for the treatment of nosocomial pneumonia ...
Market Report -- In Play ()
MSN Money - Nov 19, 2009
On The Wires Cell Therapeutics (CTIC) announced that the Ninth Circuit Court of Appeals reversed a US District Court order and ruled that co should be allowed to pursue all of its claims against ...
Judges: Seattle biotech can pursue $23M claim - Forbes
Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group - PR Newswire
Chicago Tribune - Trading Markets - RTT News